An NIH study has found there is no evidence that calcium increases the risk of age-related macular degeneration (AMD).
The findings contradict an earlier study indicating that high levels of calcium were associated with increased prevalence of AMD, but they are consistent with another suggesting that calcium has a protective role in AMD, said the United States’ National Eye Institute (NEI), which is part of the National Institutes of Health (NIH).
“Although the findings suggest that high calcium intake may be protective, the jury is still out on whether people should alter their calcium intake to prevent the onset or progression of AMD,” said deputy clinical director at NEI and the study’s lead author, Dr Emily Chew. She added there was no need to change the management of calcium intake for individuals who are already taking calcium for other medical indications.
An estimated 50% of men and 65% of women in the United States regularly use calcium supplements. Recommended daily amounts of calcium are 1,000 mg for adults 50 and younger and 1,200 mg for those older than 50.
Chew and colleagues analysed data from a previous investigation, the Age-Related Eye Disease Study (AREDS), investigating the relationship between calcium intake by diet and/or supplements and AMD onset or progression.







